Mags Tanev, our co-host here at Brains Byte Back, brings the second installment of her series The New Era of Psychedelics, exploring scientific research, therapies, and the potential benefits of psychedelic compounds and plant medicines in our societies.
In this episode, Tanev interviews Gaurav Dubey, a clinical biologist, and science blogger, to discuss research surrounding microdosing, the benefits of microdosing vs. other types of psychedelic use, and changing attitudes towards microdosing and psychedelics in our society.
Listen to this podcast on Spotify, Anchor, Apple Podcasts, Breaker, Google Podcasts, Stitcher, Overcast, Listen Notes, and Radio Public.
In addition to Dubey, Tanev also speaks with a psychedelics enthusiast with a high level of microdosing experience who wanted to keep his identity anonymous.
DARPA's O-Circuit program looks to build a new class of biologically inspired computer equipped with…
As AI races into classrooms worldwide, Google is finding that the toughest lessons on how…
The push to eat bugs is not an organic movement coming from the people, but…
As Africa’s digital economy accelerates, a new partnership between the Africa Digital Assets Summit 2026…
The State of Generative AI in the Enterprise report from Menlo Ventures found that companies…
Living therapies, made of engineered immune cells – and capable of hunting down cancer, reversing…
View Comments